Cargando…

Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials

AIM: We assessed the efficacy and safety of 5-hydroxytryptamine (5-HT(3)) receptor antagonists in adults with non-constipated irritable bowel syndrome (IBS) or diarrhea-predominant IBS (IBS-D). METHODS: We searched PubMed, MEDLINE, EMBASE, and the Cochrane Controlled Trials Register for randomized c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Yongping, Yu, Ting, Tang, Yurong, Xiong, Wenjie, Shen, Xiaoxue, Jiang, Ling, Lin, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349445/ https://www.ncbi.nlm.nih.gov/pubmed/28291778 http://dx.doi.org/10.1371/journal.pone.0172846

Ejemplares similares

Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis
por: Xie, Chen, et al.
Publicado: (2015)

Comparative effectiveness of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: a network meta-analysis of randomized controlled studies
por: Rokkas, Theodore, et al.
Publicado: (2021)

Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure
por: Chen, Yuting, et al.
Publicado: (2021)

Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome in adults
por: Dai, Yun-Kai, et al.
Publicado: (2020)

The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694.
por: Bermudez, J., et al.
Publicado: (1988)

Efficacy and safety of lactulose for the treatment of irritable bowel syndrome
por: Chen, Hong-Bin, et al.
Publicado: (2019)

Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis
por: Sun, Jian-Rong, et al.
Publicado: (2019)

Efficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
por: Li, Bing, et al.
Publicado: (2020)

Effective treatment with combination of peripheral 5‐hydroxytryptamine synthetic inhibitor and 5‐hydroxytryptamine 2 receptor antagonist on glucocorticoid‐induced whole‐body insulin resistance with hyperglycemia
por: Ma, Shaoxin, et al.
Publicado: (2016)

Efficacy of opioid receptor modulators in patients with irritable bowel syndrome: A systematic review and meta-analysis
por: Li, Xia, et al.
Publicado: (2021)

Efficacy and Safety of Acupoint Catgut Embedding for Diarrhea-Predominant Irritable Bowel Syndrome and Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
por: Wu, Jing, et al.
Publicado: (2020)

The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting
por: Palli, Swetha Rao, et al.
Publicado: (2015)

5- Hydroxytryptamine
por: Giarman, Nicholas J.
Publicado: (1958)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Upregulation of 5-Hydroxytryptamine Receptor Signaling in Coronary Arteries after Organ Culture
por: Deng, Chun-Yu, et al.
Publicado: (2014)

The Effect of 5-Hydroxytryptamine Receptor Antagonist in Preventing Pain/Limb Shrinkage Reaction Associated with Rocuronium Injection
por: He, Qixiong, et al.
Publicado: (2018)

Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome: A systematic review and meta-analysis
por: Asha, Mohammad Z., et al.
Publicado: (2020)

Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist
por: Arai, Toru, et al.
Publicado: (2022)

Ethanol Extract of Mao Jian Green Tea Attenuates Gastrointestinal Symptoms in a Rat Model of Irritable Bowel Syndrome with Constipation via the 5-hydroxytryptamine Signaling Pathway
por: Wu, Lei, et al.
Publicado: (2023)

Acupuncture and Moxibustion in the Treatment of Adult Diarrhea Irritable Bowel Syndrome: A Network Meta-analysis
por: Jiang, Xiaoxue, et al.
Publicado: (2022)

Biomarkers of Irritable Bowel Syndrome
por: Kim, Jae Hak, et al.
Publicado: (2017)

Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
por: Xiao, Lin, et al.
Publicado: (2021)

Efficacy and safety of fecal microbiota transplantation for the treatment of irritable bowel syndrome: an overview of overlapping systematic reviews
por: Zhang, Di, et al.
Publicado: (2023)

5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia
por: Pozhidaev, Ivan V., et al.
Publicado: (2020)

Long-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome
por: Chiba, Toshimi, et al.
Publicado: (2013)

Randomized controlled study of efficacy and safety of drotaverine hydrochloride in patients with irritable bowel syndrome
por: Xue, Xing-cun, et al.
Publicado: (2017)

Comparative efficacy and safety of probiotics for the treatment of irritable bowel syndrome: a systematic review and network meta-analysis protocol
por: Yang, Man, et al.
Publicado: (2019)

Efficacy and safety of fecal microbiota transplant in irritable bowel syndrome: An update based on meta‐analysis of randomized control trials
por: Abdelghafar, Yomna Ali, et al.
Publicado: (2022)

STORAGE OF 5-HYDROXYTRYPTAMINE IN MEGAKARYOCYTES
por: Tranzer, J. P., et al.
Publicado: (1972)

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017)

Epigenetic Mechanisms in Irritable Bowel Syndrome
por: Mahurkar-Joshi, Swapna, et al.
Publicado: (2020)

The Efficacy of Hypnotherapy in the Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis
por: Lee, Han Hee, et al.
Publicado: (2014)

Efficacy of different probiotic protocols in irritable bowel syndrome: A network meta-analysis
por: Liang, Ding, et al.
Publicado: (2019)

Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis
por: Zhang, Tao, et al.
Publicado: (2022)

Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children: A systematic review and meta-analysis
por: Xu, Hua-Lan, et al.
Publicado: (2021)

Serotonin in the rat prefrontal cortex controls the micturition reflex through 5‐hydroxytryptamine 2A and 5‐hydroxytryptamine 7 receptors
por: Chiba, Hiroki, et al.
Publicado: (2020)

Novel Treatment of Ventilator Dyssynchrony From Central Alveolar Hypoventilation Syndrome Utilizing Scheduled 5-Hydroxytryptamine-3 Receptor Antagonist
por: Malkoc, Aldin, et al.
Publicado: (2022)

5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials
por: Pithadia, Anand B., et al.
Publicado: (2009)

Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive–compulsive disorder: a systematic review and meta-analysis of randomized clinical trials
por: Eissazade, Negin, et al.
Publicado: (2023)

Acupuncture combined with Tongxieyaofang for diarrhea-type irritable bowel syndrome: A protocol for meta-analysis
por: Li, Yi-Lin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v559ciqco5kps6u0p7q4918d40